These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6583196)

  • 21. Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain.
    Kanazawa K; Nouda H; Sunagawa M
    J Antibiot (Tokyo); 1997 Feb; 50(2):162-8. PubMed ID: 9099227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of the in-vitro evaluation of FCE 22101.
    Wise R; Ballard RC
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():7-16. PubMed ID: 2659572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of meropenem, against gram-positive bacteria.
    Kayser FH; Morenzoni G; Strässle A; Hadorn K
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinities of cephalosporins for penicillin-binding proteins and their antibacterial activities in the presence of human serum albumin.
    Fontana R; Ligozzi M; Cornaglia G
    Clin Microbiol Infect; 2000; 6 Suppl 3():82-3. PubMed ID: 11449662
    [No Abstract]   [Full Text] [Related]  

  • 25. Binding of clavulanic acid to the penicillin-binding proteins of Aeromonas hydrophila.
    Gonzalez-Lama Z; Tejedor MT; Lupiola P; Lopez-Orge RH
    Chemioterapia; 1987 Jun; 6(2 Suppl):56-7. PubMed ID: 3509501
    [No Abstract]   [Full Text] [Related]  

  • 26. Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins.
    Piddock LJ; Traynor EA; Wise R
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():59-64. PubMed ID: 2732144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The post-antibiotic effect of imipenem and penicillin-binding protein 2.
    Erlendsdottir H; Gudmundsson S
    J Antimicrob Chemother; 1992 Aug; 30(2):231-2. PubMed ID: 1399934
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities.
    Cornaglia G; Guan L; Fontana R; Satta G
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1902-8. PubMed ID: 1416880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penicillin-binding proteins of Bacteroides fragilis.
    Botta GA; Privitera G; Menozzi MG
    J Antimicrob Chemother; 1984 Aug; 14(2):197-200. PubMed ID: 6094421
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacology and toxicology of oral cephalosporins.
    Gialdroni Grassi G
    Antibiot Chemother (1971); 1995; 47():8-33. PubMed ID: 8554309
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cephalosporins: bacterial resistance measured by penicillin-binding proteins].
    Garrido J; López F
    Rev Med Chil; 1989 Sep; 117(9):1037-43. PubMed ID: 2519470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of resistance to imipenem in Pseudomonas aeruginosa.
    Lynch MJ; Drusano GL; Mobley HL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1892-6. PubMed ID: 3125787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serine beta-lactamases and penicillin-binding proteins.
    Ghuysen JM
    Annu Rev Microbiol; 1991; 45():37-67. PubMed ID: 1741619
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in penicillin-binding proteins during the life cycle of Micromonospora.
    Cheng YR; Fontana R
    Microbiologica; 1987 Apr; 10(2):229-34. PubMed ID: 3587069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel dithiocarbamate carbapenems with anti-MRSA activity.
    Ohtake N; Imamura H; Jona H; Kiyonaga H; Shimizu A; Moriya M; Sato H; Nakano M; Ushijima R; Nakagawa S
    Bioorg Med Chem; 1998 Jul; 6(7):1089-101. PubMed ID: 9730246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bases of the antibacterial effect of beta lactam antibiotics].
    Hof H
    Immun Infekt; 1991 Dec; 19(6):175-8. PubMed ID: 1802833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The final goal: penicillin-binding proteins and the target of cephalosporins.
    Fontana R; Cornaglia G; Ligozzi M; Mazzariol A
    Clin Microbiol Infect; 2000; 6 Suppl 3():34-40. PubMed ID: 11449647
    [No Abstract]   [Full Text] [Related]  

  • 38. In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem.
    Sakagawa E; Otsuki M; Oh T; Nishino T
    J Antimicrob Chemother; 1998 Oct; 42(4):427-37. PubMed ID: 9818740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inflammatory response in pneumonia: are glucocorticosteroids useful?].
    Agustí C; Torres A
    Arch Bronconeumol; 2003 Apr; 39(4):143-5. PubMed ID: 12716553
    [No Abstract]   [Full Text] [Related]  

  • 40. Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
    Nayler JH
    J Antimicrob Chemother; 1987 Jun; 19(6):713-32. PubMed ID: 3301784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.